Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DWC20155/DWC20156 Combination in Gastritis
NCT03184415Phase 3Terminated
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jul 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DWC20155, DWC20156 in gastritis, sponsored by Daewoong Pharmaceutical. Started Jul 2017; status: terminated.
02
Drugs
DWC20155DWC20156
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT03184415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03184415.